Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ATAT enters October with an unusual split: a fresh bullish analyst initiation landed this week just as short sellers have been quietly rebuilding positions over the past month.
The most newsworthy development is HSBC's initiation of coverage with a Buy rating and a $39.70 target, filed Wednesday. That target implies roughly 23% upside from the current $32.21 close and sits comfortably above where the stock has been trading after a 6% slide over the past month. The initiation is the first new coverage action in over six months and puts a fresh institutional stamp on a name that Macquarie has been maintaining at Outperform since early 2026, with a $46 target. Older coverage from JPMorgan and Jefferies, both initiated in late 2025 with targets in the high $40s to $57, looks stale relative to where the stock is now trading, but the directional message across active coverage is unanimously bullish.
Short positioning, however, has been moving in the opposite direction. Short interest has risen 30% over the past month and is up 10% this week alone, reaching just under 2% of the free float. That remains a low absolute level, so this is not a crowded short by any measure. But the trend is clear and the pace of accumulation is worth noting. Borrow conditions offer no obvious friction: availability is extremely loose at over 2,400% of current short interest, meaning there are roughly 24 shares available to borrow for every one currently lent out. Cost to borrow has fallen 21% over the week to around 0.44%, near its lowest level of the past six weeks. Nothing in the lending market is pushing back against new short positions.
Options traders are leaning mildly bullish. The put/call ratio at 0.52 is slightly below its 20-day average of 0.58 and well inside normal range, with a z-score of minus 0.58. That is not a strong signal either way, but it does not corroborate the short-side buildup. The 52-week range on the PCR is wide, from 0.28 to 2.25, and the current reading is in the lower half of that band, suggesting calls retain a modest edge over puts.
The valuation story gives bulls something to work with. ATAT trades at around 12 times trailing earnings and just over 7 times EV/EBITDA. The price-to-book has compressed roughly 8% over the past month alongside the stock's decline, which may be part of what prompted the HSBC initiation. Factor scores are strong: EPS surprise ranks in the 97th percentile of the ORTEX universe, analyst recommendation divergence is in the 93rd percentile, and the EV/EBIT score ranks 82nd. These point to a business that consistently beats estimates and is under-owned relative to its fundamentals profile. The short score of 34.6 is benign and has been broadly stable, drifting only slightly higher over the past two weeks as SI has climbed.
On ownership, the register is concentrated. Founder Haijun Wang held just under 20% as of mid-2025, and Trip.com holds roughly 14%. Norges Bank crossed the 6% threshold in August, up from 4.5%, a quiet but meaningful vote of confidence from a systematic sovereign buyer. Capital Research entered from zero to 1.3% as of June. The top-15 institutional list shows a mix of long-only Asia specialists and index-adjacent names, with no activist on the register. First Beijing Investment, which had held just over 5%, filed a zero-stake update in May 2026, an exit worth noting for those tracking overhang.
ATAT's next earnings print is scheduled for November 19. The August report produced a 6% one-day drop, so the market's reaction function to a miss has been asymmetric on the downside. With the HSBC initiation now in the public domain and short interest still building despite loose borrow conditions, the gap between the analyst consensus and the direction of short positioning is what to watch heading into that date.
See the live data behind this article on ORTEX.
Open ATAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
